BACKGROUND: The role of peripheral tumor necrosis factor alpha (TNFα) in inflammatory bowel disease (IBD) is well established, but its central nervous system (CNS) effects are not understood. Thrombin, another mediator of inflammation in IBD, has been implicated in CNS vagal neuron apoptosis in the dorsal motor nucleus of the vagus (DMV). This study evaluates DMV TNFα exposure, characterizes effects of TNFα on DMV neurons, and identifies a relationship between DMV TNFα and thrombin in IBD. METHODS: 2,4,6-Trinitrobenzene sulfonic acid was administered via enema to induce colonic inflammation in rats. TNFα in serum, cerebrospinal fluid (CSF), and DMV tissues were determined by ELISA and DMV TNFα expression by quantitative reverse transcription PCR (RT-PCR). TNFα was administered into the fourth intracerebral ventricle (4 V) adjacent to the DMV, with and without blockade of TNF receptor 1 (TNFR1) and the thrombin receptor proteinase-activated receptor 1 (PAR1). Immunofluorescence was used to evaluate microglial activation (Cd11b) and prothrombin presence in DMV sections. Apoptosis was examined using terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) and activated caspase-3 immunofluorescence. RESULTS: IBD is associated with increased TNFα protein in serum, CSF, and DMV tissue; DMV TNFα transcription is also increased. TNFα (4 V) caused a 54 % increase in microglial activation, a 27 % increase in DMV prothrombin protein, and a 31 % increase in vagal neuron apoptosis by TUNEL. There was a 52 % increase in activated caspase-3 immunofluorescence in TNFα-treated animals (p < 0.05). All effects of 4 V TNFα were prevented by TNFR1 blockade. TNFα-induced apoptosis was prevented by PAR1 blockade. CONCLUSIONS: IBD is associated with DMV exposure to TNFα, causing excess DMV prothrombin and vagal apoptosis.
BACKGROUND: The role of peripheral tumor necrosis factor alpha (TNFα) in inflammatory bowel disease (IBD) is well established, but its central nervous system (CNS) effects are not understood. Thrombin, another mediator of inflammation in IBD, has been implicated in CNS vagal neuron apoptosis in the dorsal motor nucleus of the vagus (DMV). This study evaluates DMVTNFα exposure, characterizes effects of TNFα on DMV neurons, and identifies a relationship between DMVTNFα and thrombin in IBD. METHODS:2,4,6-Trinitrobenzene sulfonic acid was administered via enema to induce colonic inflammation in rats. TNFα in serum, cerebrospinal fluid (CSF), and DMV tissues were determined by ELISA and DMVTNFα expression by quantitative reverse transcription PCR (RT-PCR). TNFα was administered into the fourth intracerebral ventricle (4 V) adjacent to the DMV, with and without blockade of TNF receptor 1 (TNFR1) and the thrombin receptor proteinase-activated receptor 1 (PAR1). Immunofluorescence was used to evaluate microglial activation (Cd11b) and prothrombin presence in DMV sections. Apoptosis was examined using terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) and activated caspase-3 immunofluorescence. RESULTS: IBD is associated with increased TNFα protein in serum, CSF, and DMV tissue; DMVTNFα transcription is also increased. TNFα (4 V) caused a 54 % increase in microglial activation, a 27 % increase in DMVprothrombin protein, and a 31 % increase in vagal neuron apoptosis by TUNEL. There was a 52 % increase in activated caspase-3 immunofluorescence in TNFα-treated animals (p < 0.05). All effects of 4 V TNFα were prevented by TNFR1 blockade. TNFα-induced apoptosis was prevented by PAR1 blockade. CONCLUSIONS: IBD is associated with DMV exposure to TNFα, causing excess DMVprothrombin and vagal apoptosis.
Authors: Alok K Sharma; Albert E Schultze; Dale M Cooper; Rachel Y Reams; William H Jordan; Paul W Snyder Journal: Toxicol Pathol Date: 2006 Impact factor: 1.902
Authors: Molly M He; Annemarie Stroustrup Smith; Johan D Oslob; William M Flanagan; Andrew C Braisted; Adrian Whitty; Mark T Cancilla; Jun Wang; Alexey A Lugovskoy; Josh C Yoburn; Amy D Fung; Graham Farrington; John K Eldredge; Eric S Day; Leslie A Cruz; Teresa G Cachero; Stephan K Miller; Jessica E Friedman; Ingrid C Choong; Brian C Cunningham Journal: Science Date: 2005-11-11 Impact factor: 47.728
Authors: Tanja Spoettl; Martin Hausmann; Frank Klebl; Andrea Dirmeier; Bodo Klump; Joerg Hoffmann; Hans Herfarth; Antje Timmer; Gerhard Rogler Journal: Inflamm Bowel Dis Date: 2007-06 Impact factor: 5.325
Authors: K L Lambertsen; B H Clausen; C Fenger; H Wulf; T Owens; F Dagnaes-Hansen; M Meldgaard; B Finsen Journal: Neuroscience Date: 2006-12-11 Impact factor: 3.590
Authors: Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman Journal: Proc Natl Acad Sci U S A Date: 2008-10-27 Impact factor: 11.205
Authors: Thomas Fréour; Anne Jarry; Kalyane Bach-Ngohou; Thomas Dejoie; Chantal Bou-Hanna; Marc G Denis; Jean-François Mosnier; Christian L Laboisse; Damien Masson Journal: Int J Mol Med Date: 2009-01 Impact factor: 4.101
Authors: Yang Yu; Yiling Cao; Balyssa Bell; Xiaolei Chen; Robert M Weiss; Robert B Felder; Shun-Guang Wei Journal: Hypertension Date: 2019-06-03 Impact factor: 10.190
Authors: J S Kim; R A Kirkland; S H Lee; C R Cawthon; K W Rzepka; D M Minaya; G de Lartigue; K Czaja; C B de La Serre Journal: Physiol Behav Date: 2020-07-16
Authors: Kyoko Watanabe; Maša Umićević Mirkov; Christiaan A de Leeuw; Martijn P van den Heuvel; Danielle Posthuma Journal: Nat Commun Date: 2019-07-19 Impact factor: 14.919